1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow MT-401-OTS: new trials by email Literature Review of MT-401-OTS trials Research Report on MT-401-OTS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of MT-401-OTS in Patients With Relapsed AML or MDS MT-401-OTS - Acute Myeloid Leukemia, in Relapse, MDS | Phase 1 | Recruiting | Marker Therapeutics, Inc. | 40 | 2025-06-16 | 2025-12-16 |
United States (1)